Orion Group Holdings, Inc.
NYSE:ORNEngineering & Construction
+$0.48 today
- Market cap
- $300.07M
- Beta
- 1.38
- P/E (TTM)
- 73.6
- EPS (TTM)
- $0.21
Volume 0.92M
Average 0.34M
ORN Cash & Equivalents
Cash on hand and highly liquid investments that can be converted to cash almost immediately.
Orion Group Holdings, Inc.NYSE: ORN
Cash & Equivalents · Q1 FY2026 · quarter ended Mar 2026
Cash & equivalents falls 51.7% from a year ago
Cash & equivalents stood at $6.25M at the end of Q1 FY2026, down 51.7% from a year earlier and up 293.8% from the prior quarter. Over 3 fiscal years it compounded at -25.1% a year.
Context
- Cash & equivalents amounted to 1.3% of total assets at the end of Q1 FY2026, down 1.8 pp from a year earlier.
- Cash & equivalents increased in 1 of the last 3 fiscal years.
- FY2025 was the lowest annual figure in the 4 fiscal years shown.
What to watch
Whether cash & equivalents keeps falling in the next quarterly balance sheet after a -51.7% change from a year earlier.
Sources:Balance SheetText generated from reported figures; not investment advice.
Cash & Equivalents history
USD · from the balance sheet
- Latest · FY2025
- 1.59M USD
- Year-over-year change
- -94.4%
- 4-year CAGR
- -40.0%
| Period | Period end | Cash & Equivalents | YoY change |
|---|---|---|---|
| FY2025 | 2025-12-31 | 1.59M | -94.4% |
| FY2024 | 2024-12-31 | 28.32M | -8.5% |
| FY2023 | 2023-12-31 | 30.94M | +717.6% |
| FY2022 | 2022-12-31 | 3.78M | -69.2% |
| FY2021 | 2021-12-31 | 12.29M | — |
Cash & Equivalents vs competitors
How ORN compares with its peers on the latest reported figures
- Peers report in different currencies, so cash & equivalents is compared through growth and share of total assets rather than absolute size.
- Its year-over-year change of -51.7% is the lowest of 11, against a peer median of +4.3%.
- Cash & equivalents amounts to 1.3% of total assets for ORN, versus a peer median of 9.4%.
| Company | Period | Latest balance | YoY | 3-year CAGR | % of assets |
|---|---|---|---|---|---|
| Mar 2026 | $233.02M USD | +25.6% | +62.5% | 37.8% | |
| Mar 2026 | $78.49M USD | +263.0% | +164.6% | 55.2% | |
| Mar 2026 | £73.38M GBP | -19.4% | +3.7% | 63.2% | |
SRTAStrata Critical Medical, Inc. | Mar 2026 | $58.72M USD | +68.6% | -9.2% | 17.9% |
| Apr 2026 | $38.69M USD | +2.4% | +81.0% | 4.3% | |
| Feb 2026 | $34.57M USD | -48.4% | -28.3% | 9.5% | |
| Apr 2026 | $28.19M USD | +11.7% | -19.3% | 5.5% | |
| Apr 2026 | $17.92M USD | -13.0% | -17.1% | 1.0% | |
| Feb 2026 | $7.45M USD | -2.8% | -11.9% | 9.3% | |
| Mar 2026 | $6.25M USD | -51.7% | -25.1% | 1.3% | |
| Mar 2026 | $1.18M USD | +6.1% | -39.3% | 1.9% | |
| Peer median (excluding ORN) | — | +4.3% | -10.5% | 9.4% | |
Competitors are the stored peer set for ORN. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Balance Sheet
Metric | FY2021 Dec 2021 | FY2022 Dec 2022 | FY2023 Dec 2023 | FY2024 Dec 2024 | FY2025 Dec 2025 |
|---|---|---|---|---|---|
| Cash & Equivalents | 12.29M | 3.78M | 30.94M | 28.32M | 1.59M |
| Short-term Investments | 0 | 0 | 0 | 0 | 0 |
| Net Receivables | 176.87M | 205.46M | 229.29M | 229.95M | 259.76M |
| Inventory | 1.43M | 2.86M | 2.7M | 1.97M | 2.43M |
| Other Current Assets | 7.34M | 8.23M | 8.89M | 9.08M | 14.38M |
| Total Current Assets | 197.93M | 220.34M | 271.82M | 269.33M | 278.16M |
| Property, Plant & Equipment (Net) | 135.9M | 131.79M | 137.13M | 139.01M | 126.97M |
| Goodwill | 0 | 0 | 0 | 0 | 0 |
| Intangible Assets | 8.56M | 7.32M | 0 | 0 | 0 |
| Long-term Investments | 1.1M | 0 | 0 | 0 | 0 |
| Tax Assets | 41K | 70K | 26K | 17K | 17K |
| Other Non-current Assets | 8.22M | 7.64M | 7.92M | 8.97M | 9.51M |
| Total Non-current Assets | 153.82M | 146.82M | 145.08M | 147.99M | 136.49M |
| Total Assets | 351.75M | 367.16M | 416.89M | 417.32M | 414.65M |
| Account Payables | 49.14M | 88.8M | 82.82M | 98.45M | 109.13M |
| Short-term Debt | 46.4M | 43.73M | 13.45M | 18.55M | 13.72M |
| Tax Payables | 601K | 522K | 570K | 507K | 197K |
| Deferred Revenue | 27M | 37.72M | 14.16M | 47.37M | 49.1M |
| Other Current Liabilities | 28.72M | 10.86M | 67.81M | (18.13M) | 1.05M |
| Total Current Liabilities | 161.74M | 189.24M | 215.92M | 191.17M | 203.91M |
| Long-term Debt | 259K | 716K | 23.74M | 22.75M | 6.09M |
| Deferred Tax Liabilities | 169K | 211K | 64K | 28K | 80K |
| Deferred Revenue (Non-current) | 16.18M | 16.8M | 0 | 0 | 0 |
| Other Non-current Liabilities | 2.76M | 277K | 25.32M | 20.5M | 1.6M |
| Total Non-current Liabilities | 41.91M | 40.12M | 79.5M | 75.47M | 51.71M |
| Total Liabilities | 203.65M | 229.36M | 295.42M | 266.64M | 255.62M |
| Common Stock | 317K | 328K | 333K | 397K | 406K |
| Retained Earnings | (31.56M) | (44.17M) | (62.05M) | (63.69M) | (61.2M) |
| Accumulated OCI | 0 | 0 | 0 | 0 | 0 |
| Other Stockholders Equity | 0 | 0 | 0 | 0 | 0 |
| Minority Interest | 0 | 0 | 0 | 0 | 0 |
| Total Equity | 148.1M | 137.8M | 121.48M | 150.68M | 159.03M |
| Total Debt | 69.21M | 66.56M | 85.49M | 94.46M | 50.38M |
| Net Debt | 56.92M | 62.78M | 54.55M | 66.15M | 42.71M |
Orion Group Holdings, Inc.
NYSE:ORN
Intrinsic Alpha fair value
Locked
Current Price
$7.38
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.